LSKL TFA
LSKL TFA is a blood-brain barrier permeable TGF-β1 antagonist derived from LAP. It functions by inhibiting the TSP-1/LAP interaction, thereby blocking TGF-β1 activation. This mechanism has demonstrated efficacy in preclinical models of subarachnoid hemorrhage, renal fibrosis, and liver fibrosis.
Product Specifications
Product Name Alternative
Field of Research
Immunology & Inflammation, Stem Cell & Developmental Biology
Purity
99.33% (May vary between batches)
Solubility
DMSO:200 mg/mL (349.27 mM) ; H2O:80 mg/mL (139.71 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (8.73 mM)
Molecular Weight
572.62
Storage Conditions
Keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog